Evidence map›Paper›PMID 39872801›Full record

ReviewIn vitro models2022

Balloon expandable coronary stent materials: a systematic review focused on clinical success.

Jithin Vishnu, Geetha Manivasagam, Diego Mantovani, Anjaneyulu Udduttula, Melanie J Coathup, Ketul C Popat, Pei-Gen Ren, K G Prashanth

Erratum issuedAbstract readReview
In one paragraph

Review in In vitro models, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Biomaterials for Drug Delivery and Human Applications.Materials (Basel, Switzerland) · 2024
    Review
  10. Article
  11. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Jithin VishnuCentre for Biomaterials, Cellular and Molecular Theranostics, CBCMT, Vellore Institute of Technology, Vellore, 632014 India.
Geetha ManivasagamCentre for Biomaterials, Cellular and Molecular Theranostics, CBCMT, Vellore Institute of Technology, Vellore, 632014 India.ORCID 0000-0003-3326-3176
Diego MantovaniLab. for Biomaterials and Bioengineering, Department of Mining, Metallurgical and Materials Engineering & CHU de Quebec Research Centre, Laval University, Quebec City, QC Canada.
Anjaneyulu UdduttulaCenter for Energy Metabolism and Reproduction, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, 518055 Guangdong China.
Melanie J CoathupBiionix Cluster and College of Medicine, University of Central Florida, 6900 Lake Nona Blvd, Orlando, FL 32827 USA.
Ketul C PopatDepartment of Mechanical Engineering, Colorado State University, Fort Collins, CO 80523 USA.
Pei-Gen RenCenter for Energy Metabolism and Reproduction, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, 518055 Guangdong China.
K G PrashanthCentre for Biomaterials, Cellular and Molecular Theranostics, CBCMT, Vellore Institute of Technology, Vellore, 632014 India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Balloon expandable coronary stenting has revolutionized the field of interventional cardiology as a potential, minimally invasive modality for treating coronary artery disease. Even though stenting is successful compared to angioplasty (that leaves no stent in place), still there are many associated clinical complications. Bare metal stents are associated with in-stent restenosis caused mostly by neointimal hyperplasia, whereas success of drug-eluting stents comes at the expense of late-stent thrombosis and neoatherosclerosis. Even though innovative and promising, clinical trials with bioabsorbable stents reported thrombosis and a rapid pace of degradation without performing scaffolding action in several instances. It should be noted that a vast majority of these stents are based on a metallic platform which still holds the potential to mitigate major cardiovascular events and reduced economic burden to patients, alongside continuous improvement in stent technology and antiplatelet regimes. Hence, a systematic review was conducted following PRISMA guidelines to assess the clinically relevant material properties for a metallic stent material. From a materials perspective, the major causes identified for clinical failure of stents are inferior mechanical properties and blood-material interaction-related complications at the stent surface. In addition to these, the stent material should possess increased radiopacity for improved visibility and lower magnetic susceptibility values for artefact reduction. Moreover, the review provides an overview of future scope of percutaneous coronary interventional strategy. Most importantly, this review highlights the need for an interdisciplinary approach by clinicians, biomaterial scientists, and interventional cardiologists to collaborate in mitigating the impediments associated with cardiovascular stents for alleviating sufferings of millions of people worldwide. Graphical abstract:

Indexed as

Bioabsorbable stentsCoronary artery diseaseIn-stent restenosis, Bare metal stentsMagnetic susceptibilityRadiopacityThrombosis

Identifiers

PMID39872801
PMCPMC11756493

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.